Literature DB >> 10518042

Enterococcus faecalis aggregation substance promotes opsonin-independent binding to human neutrophils via a complement receptor type 3-mediated mechanism.

N N Vanek1, S I Simon, K Jacques-Palaz, M M Mariscalco, G M Dunny, R M Rakita.   

Abstract

Enterococcus faecalis aggregation substance (AS) mediates efficient adhesion between bacteria, thereby facilitating plasmid exchange as an integral part of a bacterial sex pheromone system. We examined the interaction of AS-bearing E. faecalis with human neutrophils (PMNs), an important component of the host defense system. AS promoted a markedly increased opsonin-independent bacterial binding to PMNs. Adhesion was dependent on the expression of the enterococcal Asc10 protein, which contains two Arg-Gly-Asp (RGD) sequences, and addition of exogenous RGD-containing peptides inhibited AS-mediated binding by 66%. AS-mediated adhesion was inhibited by 85% by anti-human complement receptor type 3 (CR3) monoclonal antibodies or by use of PMNs from a patient with leukocyte adhesion deficiency. However, AS-bearing E. faecalis cells were unable to bind to CHO-Mac-1 cells, expressing functionally active CR3, suggesting the potential need for additional PMN surface receptors for bacterial adhesion. Monoclonal antibodies against integrin-associated protein (CD47) and L-selectin, both of which may interact with CR3 and bind to ligands on E. faecalis, also inhibited AS-dependent binding. The non-opsonic binding of E. faecalis to PMNs may play an important role in this organism's pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518042     DOI: 10.1111/j.1574-695X.1999.tb01371.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  28 in total

1.  Analysis of functional domains of the Enterococcus faecalis pheromone-induced surface protein aggregation substance.

Authors:  C M Waters; G M Dunny
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

2.  Aggregation substance increases adherence and internalization, but not translocation, of Enterococcus faecalis through different intestinal epithelial cells in vitro.

Authors:  S Sartingen; E Rozdzinski; A Muscholl-Silberhorn; R Marre
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 3.  Relationships between enterococcal virulence and antimicrobial resistance.

Authors:  L M Mundy; D F Sahm; M Gilmore
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

4.  Pathogenic Mechanisms of Enterococcal Endocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

5.  Tales of conjugation and sex pheromones: A plasmid and enterococcal odyssey.

Authors:  Don B Clewell
Journal:  Mob Genet Elements       Date:  2011-05

Review 6.  Biological diversity of prokaryotic type IV secretion systems.

Authors:  Cristina E Alvarez-Martinez; Peter J Christie
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

Review 7.  Enterococcus infection biology: lessons from invertebrate host models.

Authors:  Grace J Yuen; Frederick M Ausubel
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

8.  Multiple functional domains of Enterococcus faecalis aggregation substance Asc10 contribute to endocarditis virulence.

Authors:  Olivia N Chuang; Patrick M Schlievert; Carol L Wells; Dawn A Manias; Timothy J Tripp; Gary M Dunny
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

9.  Borrelia burgdorferi BBB07 interaction with integrin alpha3beta1 stimulates production of pro-inflammatory mediators in primary human chondrocytes.

Authors:  Aruna K Behera; Enrique Durand; Carla Cugini; Styliani Antonara; Lori Bourassa; Ethan Hildebrand; Linden T Hu; Jenifer Coburn
Journal:  Cell Microbiol       Date:  2007-09-06       Impact factor: 3.715

10.  The aggregation domain of aggregation substance, not the RGD motifs, is critical for efficient internalization by HT-29 enterocytes.

Authors:  Christopher M Waters; Carol L Wells; Gary M Dunny
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.